Can Fite Biopharma
CANF
#9777
Rank
NZ$20.38 M
Marketcap
$3.34
Share price
-0.51%
Change (1 day)
-0.39%
Change (1 year)

P/S ratio for Can Fite Biopharma (CANF)

P/S ratio as of November 2024 (TTM): 16.1

According to Can Fite Biopharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.91. At the end of 2023 the company had a P/S ratio of 18.9.

P/S ratio history for Can Fite Biopharma from 2012 to 2023

PS ratio at the end of each year

Year P/S ratio Change
202318.9-16.2%
202222.5-40.56%
202137.91.2%
202037.5484.11%
20196.41-1.6%
20186.52-77.8%
201729.4-84.91%
2016195-21.39%
2015247
2014N/A
2013N/A
2012N/A